Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)
Public ClinicalTrials.gov record NCT01524783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced NET of GI or Lung Origin
Study identification
- NCT ID
- NCT01524783
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 302 participants
Conditions and interventions
Interventions
- Everolimus Drug
- Placebo Drug
- Best suportive care (BSC) Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2012
- Primary completion
- Nov 27, 2014
- Completion
- Aug 6, 2020
- Last update posted
- Aug 4, 2021
2012 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Diego - Moores Cancer Center Regulatory | La Jolla | California | 92093-0658 | — |
| Scripps Clinic Regulatory | La Jolla | California | 92121 | — |
| Cedars Sinai Medical Center SC | Los Angeles | California | 90048 | — |
| University of Colorado Cancer Centre SC | Aurora | Colorado | 80045 | — |
| H Lee Moffitt Cancer Center and Research Institute HLM | Tampa | Florida | 33612 | — |
| University of Chicago UC SC | Chicago | Illinois | 60637 | — |
| Goshen Center for Cancer Care IU Health SC | Indianapolis | Indiana | 46202 | — |
| Dana Farber Cancer Institute SC | Boston | Massachusetts | 02215 | — |
| Memorial Sloan Kettering MSkCC SC | New York | New York | 10017 | — |
| Montefiore Medical Center MMC | The Bronx | New York | 10467 | — |
| Oregon Health and Science University OH&SU | Portland | Oregon | 97239 | — |
| Vanderbilt University Medical Center Vanderbilt Med Ctr | Nashville | Tennessee | 37232 | — |
| Texas Oncology P A Texas Oncology Amarillo | Dallas | Texas | 75251 | — |
| Texas Oncology P A TX Oncology Baylor | Dallas | Texas | 75251 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| University of Texas MD Anderson Cancer Center UT MD Anderson Cancer Ctr | Houston | Texas | 77030 | — |
| University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc | Madison | Wisconsin | 53792-6164 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01524783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01524783 live on ClinicalTrials.gov.